FAI is pleased to announce that we have procured the latest version portable medical isolation unit PMIU solid-shell EpiShuttle manufactured in Norway by EpiGuard AS.

  • After an induction and training period for our teams, FAI is now ready to commence dedicated PMIU missions as of 08 February 2020.

  • We have installed a customised stretcher configuration on a Challenger CL604 aircraft, with specific EpiShuttle equipment and accessory modules ready to deploy. We have deployed a dedicated team of 4 ICU Flight Doctors and 8 Flight Paramedics, now trained in accordance with the ECDC European Center for Disease Control Technical Directive: Infection Prevention and Control for the Care of Patients with 2019-nCoV in Healthcare Settings, February 2020

FAI AG
FAI AG

Transport Capabilities

  • Confirmed Cases of SARS-CoV-2 (2019-nCoV)
    Based on our current PMIU capability FAI will offer transportation of patients with confirmed “2019-nCoV“ infection on a case by case basis. All such flights will be operated in an EpiShuttle PMIU unit with dedicated trained medical teams and equipment.

  • Case Contacts with negative SARS-CoV-2 serology
    Based on our current PMIU capability FAI will offer transportation of patients who are positive case contacts as defined, with negative “2019-nCoV“ serology test results, on a case by case basis. All such flights will be operated in an EpiShuttle PMIU unit with dedicated trained medical teams and equipment.

  • Patients with conditions unrelated to SARS-CoV-2 (2019-nCoV)
    Air ambulance transports for patients with unrelated diagnoses, from locations where the outbreak is established, will similarly be reviewed on a case-by-case basis.

Covid-19 News

Contact us!